Transforming growth factor beta-2 proprotein (TGF-β2)

Transforming growth factor beta‑2 proprotein (TGF‑β₂) is a secreted cytokine belonging to the transforming growth factor‑beta superfamily. It plays essential roles during embryonic development and throughout life by regulating cell proliferation, differentiation, migration/motility, apoptosis (programmed cell death), angiogenesis (formation of blood vessels), heart development, bone formation/regulation within the skeleton, wound healing, immune system function, and maintenance of extracellular matrix structure. The protein is synthesized as an inactive precursor that undergoes proteolytic processing into latency-associated peptide (LAP) plus mature peptide forms; it signals through binding to specific receptors on target cells which activate intracellular SMAD transcription factors. Mutations affecting TGFB2 cause connective tissue disorders such as Loeys-Dietz syndrome type IV characterized by vascular abnormalities. Dysregulation has been implicated both in cancer suppression/progression depending on context.

Other names

Transforming growth factor beta 2TGF-beta 2TGFβ2Glioblastoma-derived T-cell suppressor factorG-TSFBSC-1 cell growth inhibitorPolyerginCetermin

Drugs that target this molecule typically act by inhibiting ligand binding to its receptor or blocking downstream signal transduction through SMAD proteins, thereby modulating cellular processes such as proliferation, differentiation, immune response, and extracellular matrix production. This is inferred from its role as a cytokine/growth factor activating receptor-mediated pathways.